{"title":"某三级教学医院选择性关节置换术中局部麻醉的自由使用及毒性风险","authors":"Luke McConnell, J. Bulman","doi":"10.1177/25160435221135307","DOIUrl":null,"url":null,"abstract":"Background Local anaesthetic systemic toxicity (LAST) is a life-threatening potential complication that may follow the administration of local anaesthetic (LA) drugs, and is cumulative across the drug class. Local anaesthetics are commonly administered via different routes for elective orthopaedic procedures – both by anaesthetists and surgeons. We hypothesized that total doses of LA may be routinely encroaching upon toxicity. Methods All total hip or knee arthroplasties (THAs and TKAs) performed within a 3 month period at the John Hunter Hospital (tertiary referral centre and teaching hospital) were audited to assess total administration of LA. Demographics, surgical characteristics, use of general anaesthesia or sedation, and use of local anaesthetic via any route of administration was recorded. For each patient, a weight-based theoretical maximum safe dose was calculated and compared against the dose they received. Data is presented as mean ± SD, percentages. Statistical significance was determined at p < 0.05. Results 130 THAs and TKAs were identified within the audit period. 52 patients exceeded their drug-class theoretical maximum safe dose. 49 patients exceeded their weight-based maximum dose for a single LA agent, in all cases ropivacaine. Non-obese individuals receive significantly higher mean dose than obese individuals (119.4% [98.6–140.3] vs 78.82% [65.95–91.69], p = 0.001). No LAST events were identified. Conclusions Patients who received elective total hip or knee arthroplasties were exposed to concerningly high total doses of local anaesthetic, suggesting that greater awareness of the additive toxicity of drugs within this class is required.","PeriodicalId":73888,"journal":{"name":"Journal of patient safety and risk management","volume":"63 1","pages":"256 - 262"},"PeriodicalIF":0.6000,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Liberal use of local anaesthetic and the risk of toxicity in elective arthroplasties at a tertiary teaching hospital\",\"authors\":\"Luke McConnell, J. Bulman\",\"doi\":\"10.1177/25160435221135307\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Local anaesthetic systemic toxicity (LAST) is a life-threatening potential complication that may follow the administration of local anaesthetic (LA) drugs, and is cumulative across the drug class. Local anaesthetics are commonly administered via different routes for elective orthopaedic procedures – both by anaesthetists and surgeons. We hypothesized that total doses of LA may be routinely encroaching upon toxicity. Methods All total hip or knee arthroplasties (THAs and TKAs) performed within a 3 month period at the John Hunter Hospital (tertiary referral centre and teaching hospital) were audited to assess total administration of LA. Demographics, surgical characteristics, use of general anaesthesia or sedation, and use of local anaesthetic via any route of administration was recorded. For each patient, a weight-based theoretical maximum safe dose was calculated and compared against the dose they received. Data is presented as mean ± SD, percentages. Statistical significance was determined at p < 0.05. Results 130 THAs and TKAs were identified within the audit period. 52 patients exceeded their drug-class theoretical maximum safe dose. 49 patients exceeded their weight-based maximum dose for a single LA agent, in all cases ropivacaine. Non-obese individuals receive significantly higher mean dose than obese individuals (119.4% [98.6–140.3] vs 78.82% [65.95–91.69], p = 0.001). No LAST events were identified. Conclusions Patients who received elective total hip or knee arthroplasties were exposed to concerningly high total doses of local anaesthetic, suggesting that greater awareness of the additive toxicity of drugs within this class is required.\",\"PeriodicalId\":73888,\"journal\":{\"name\":\"Journal of patient safety and risk management\",\"volume\":\"63 1\",\"pages\":\"256 - 262\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2022-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of patient safety and risk management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/25160435221135307\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of patient safety and risk management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25160435221135307","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
背景:局部麻醉全身毒性(LAST)是局部麻醉(LA)药物使用后可能出现的危及生命的潜在并发症,并且在整个药物类别中具有累积性。局部麻醉通常通过不同的途径进行选择性骨科手术-由麻醉师和外科医生。我们假设,总剂量的洛杉矶可能是例行侵犯毒性。方法对约翰亨特医院(三级转诊中心和教学医院)3个月内进行的所有全髋关节或膝关节置换术(tha和tka)进行审计,以评估LA的总管理。记录患者的人口统计学、手术特点、全麻或镇静的使用情况,以及通过任何给药途径使用局部麻醉。对每位患者,计算出基于体重的理论最大安全剂量,并与他们接受的剂量进行比较。数据以mean±SD,百分比表示。p < 0.05为差异有统计学意义。结果在审核期间共发现130处tha和tka。52例患者超过了其药物类别理论最大安全剂量。49例患者服用单一LA药物超过了以体重为基础的最大剂量,所有病例均为罗哌卡因。非肥胖者的平均剂量显著高于肥胖者(119.4% [98.6-140.3]vs 78.82% [65.95-91.69], p = 0.001)。未发现LAST事件。结论:接受选择性全髋关节或膝关节置换术的患者暴露于高剂量局部麻醉剂中,提示需要对该类药物的附加毒性有更多的认识。
Liberal use of local anaesthetic and the risk of toxicity in elective arthroplasties at a tertiary teaching hospital
Background Local anaesthetic systemic toxicity (LAST) is a life-threatening potential complication that may follow the administration of local anaesthetic (LA) drugs, and is cumulative across the drug class. Local anaesthetics are commonly administered via different routes for elective orthopaedic procedures – both by anaesthetists and surgeons. We hypothesized that total doses of LA may be routinely encroaching upon toxicity. Methods All total hip or knee arthroplasties (THAs and TKAs) performed within a 3 month period at the John Hunter Hospital (tertiary referral centre and teaching hospital) were audited to assess total administration of LA. Demographics, surgical characteristics, use of general anaesthesia or sedation, and use of local anaesthetic via any route of administration was recorded. For each patient, a weight-based theoretical maximum safe dose was calculated and compared against the dose they received. Data is presented as mean ± SD, percentages. Statistical significance was determined at p < 0.05. Results 130 THAs and TKAs were identified within the audit period. 52 patients exceeded their drug-class theoretical maximum safe dose. 49 patients exceeded their weight-based maximum dose for a single LA agent, in all cases ropivacaine. Non-obese individuals receive significantly higher mean dose than obese individuals (119.4% [98.6–140.3] vs 78.82% [65.95–91.69], p = 0.001). No LAST events were identified. Conclusions Patients who received elective total hip or knee arthroplasties were exposed to concerningly high total doses of local anaesthetic, suggesting that greater awareness of the additive toxicity of drugs within this class is required.